These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14760874)

  • 1. Vasoactive drugs and the kidney.
    Lee RW; Di Giantomasso D; May C; Bellomo R
    Best Pract Res Clin Anaesthesiol; 2004 Mar; 18(1):53-74. PubMed ID: 14760874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of acute renal failure: role of vaso-active drugs, mannitol and diuretics.
    Girbes AR
    Int J Artif Organs; 2004 Dec; 27(12):1049-53. PubMed ID: 15645615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure.
    Lauschke A; Teichgräber UK; Frei U; Eckardt KU
    Kidney Int; 2006 May; 69(9):1669-74. PubMed ID: 16572117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is renal dose dopamine protective or therapeutic? Yes.
    Carcoana OV; Hines RL
    Crit Care Clin; 1996 Jul; 12(3):677-85. PubMed ID: 8839599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in renal function induced by anesthesia].
    Mercatello A
    Ann Fr Anesth Reanim; 1990; 9(6):507-24. PubMed ID: 2278418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic support and the role of dopamine.
    Bellomo R; Cole L; Ronco C
    Kidney Int Suppl; 1998 May; 66():S71-4. PubMed ID: 9573578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of dopamine in acute renal failure: a meta-analysis.
    Kellum JA; M Decker J
    Crit Care Med; 2001 Aug; 29(8):1526-31. PubMed ID: 11505120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesna: a novel renoprotective antioxidant in ischaemic acute renal failure.
    Mashiach E; Sela S; Weinstein T; Cohen HI; Shasha SM; Kristal B
    Nephrol Dial Transplant; 2001 Mar; 16(3):542-51. PubMed ID: 11239029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of acute renal failure in the critically ill.
    Ronco C; Bellomo R
    Nephron Clin Pract; 2003 Jan; 93(1):C13-20. PubMed ID: 12411754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetized rats.
    Johannes T; Mik EG; Klingel K; Goedhart PT; Zanke C; Nohé B; Dieterich HJ; Unertl KE; Ince C
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):870-9. PubMed ID: 19413586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
    Pea F; Porreca L; Baraldo M; Furlanut M
    J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional haemodynamic effects of dopamine and its prodrugs L-dopa and gludopa in the rat and in the glycerol-treated rat as a model for acute renal failure.
    Drieman JC; van Kan FJ; Thijssen HH; van Essen H; Smits JF; Struijker Boudier HA
    Br J Pharmacol; 1994 Apr; 111(4):1117-22. PubMed ID: 8032598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure.
    Conger JD; Falk SA; Yuan BH; Schrier RW
    Kidney Int; 1989 May; 35(5):1126-32. PubMed ID: 2528019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: assessed by measuring retinol binding protein (RBP).
    Tang AT; El-Gamel A; Keevil B; Yonan N; Deiraniya AK
    Eur J Cardiothorac Surg; 1999 May; 15(5):717-21; discussion 721-2. PubMed ID: 10386423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of dopamine A-1 agonists in the management of acute renal failure.
    Singer I; Epstein M
    Am J Kidney Dis; 1998 May; 31(5):743-55. PubMed ID: 9590183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamics and renal function during administration of low-dose dopamine in severely ill patients.
    Pereira CN; Machado FR; Guimarães HP; Senna AP; do Amaral JL
    Sao Paulo Med J; 2004 Jul; 122(4):141-6. PubMed ID: 15543367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we need a dopaminergic agent in the management of the critically ill?
    Vincent JL
    J Auton Pharmacol; 1990; 10 Suppl 1():s123-7. PubMed ID: 1983006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there still a place for dopamine in the modern intensive care unit?
    Debaveye YA; Van den Berghe GH
    Anesth Analg; 2004 Feb; 98(2):461-468. PubMed ID: 14742388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition?
    Jones D; Bellomo R
    J Intensive Care Med; 2005; 20(4):199-211. PubMed ID: 16061903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.